Our team includes pioneers in genome editing and leaders in cell and gene therapy who are committed to solving significant medical problems. LeadershipBoard of DirectorsScientific Advisory Board Michael AmorosoPresident, Chief Executive Officer Derek Jantz, Ph.D.Chief Scientific Officer, Co-Founder Jeff Smith, Ph.D.Chief Technology Officer, Co-Founder Cindy AtwellSenior Vice President of Business Development and Alliance Management Alex KellyChief Financial Officer Dawn LosingerActing Head of Human Resources and Director, Talent Acquisition & Management Alan List, M.D.Chief Medical Officer Dario ScimecaGeneral Counsel Kevin Buehler Michael AmorosoPresident, Chief Executive Officer Stanley Frankel, M.D. Geno Germano Derek Jantz, Ph.D.Chief Scientific Officer, Co-Founder Shari Lisa Piré, J.D. Raymond Schinazi, Ph.D., DSc Shalini Sharp Sam Wadsworth, Ph.D. Kenneth Anderson, M.D., Ph.D. Samuel Broder, M.D. Hagop Kantarjian, M.D. Raymond Schinazi, Ph.D., DSc Cameron Turtle, MBBS, Ph.D.
